ロード中...
A Case of Immunotherapy-Induced Colitis Complicated by Perforation and Treated with Infliximab Postoperatively
The advent of checkpoint inhibitor therapy in medical oncology has led to an increase in hospitalizations for immune-related adverse effects. Severe colitis has been reported in approximately 5% of patients treated with cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) inhibitors, such as ipilimu...
保存先:
| 出版年: | Case Rep Oncol Med |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6679838/ https://ncbi.nlm.nih.gov/pubmed/31428491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9069354 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|